Related Articles
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
Telomerase (GV1001) vaccination together with gemcitabine in advanced pancreatic cancer patients
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen